Claim Missing Document
Check
Articles

Found 12 Documents
Search

Gerakan Bumil Setia di Desa Sembubuk Muaro Jambi Tahun 2023 Suryanti, Yuli; Suryani, Suryani; Soleh, Evrina Solvia
Jurnal Abdimas Kesehatan (JAK) Vol. 7 No. 3 (2025): November
Publisher : Universitas Baiturrahim

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36565/jak.v7i3.911

Abstract

The MMR target in 2024 is 183 per 100,000 live births. This figure is still very far from the current condition of 305 per 100,000 live births. Likewise, the estimated prevalence of stunting in toddlers in 2024 with a target of 14% is still far from the current condition of 24.4%. In order to accelerate the reduction of MMR and the prevalence of stunting in toddlers, one of the efforts made is through increasing the quality of maternal health services (antenatal care) to 6 times. Maternal health services 6 times have only reached 2,583,073 pregnant women out of the target of 4,897,988 pregnant women, and the number of pregnant women who received Hb examination services is lower, namely 1,474,723 mothers, those examined by doctors at the 1st visit (K1) were 771,936 mothers, and those examined by doctors at the 5th visit (K5) were 543,510 mothers. The Bumil Setia Movement refers to the Healthy Pregnant Women Movement program from the Indonesian Ministry of Health which seeks to reduce stunting in Indonesia starting from before pregnancy, during pregnancy, and after birth. The Bumil Setia activity aims to increase awareness and compliance of pregnant women in undergoing prenatal checkups, maintaining health during pregnancy, and improving understanding of managing food/diet during pregnancy. This activity is carried out by providing information and education both in groups and individually by conducting home visits to pregnant women in Sembubuk Village. There has been an increase in maternal compliance in checking their pregnancy from previously only 48.2% to 76.5%. Most pregnant women have regularly attended prenatal classes for 4 times (82.4%). 58.8% of pregnant women who consume iron supplements tablets > 90 tablets. Most pregnant women with Hb levels > 11gr% are 12 pregnant women (70.6%).
Hubungan Lama Penggunaan Kontrasepsi Suntik Depo Medroxy Progesteron Acetate (DMPA) Dengan Kadar Kolestrol Total Pada Akseptor KB Veradilla; Mauluddina, Faulia; Saswita, Reni; Suryanti, Yuli
JURNAL KEBIDANAN AKADEMI KEBIDANAN BUDI MULIA PALEMBANG Vol 15 No 2 (2025): Jurnal Kebidanan: Jurnal Ilmu Kesehatan Budi Mulia
Publisher : STIKes Budi Mulia Sriwijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35325/kebidanan.v15i2.582

Abstract

Birth planning and readiness to overcome complications Depo Medroxy Progesterone Acetate (DMPA) injectable contraception is a popular hormonal contraceptive method among women. Its ease of use and effectiveness in preventing pregnancy make DMPA a popular choice. However, long-term use of DMPA has been associated with several side effects, one of which is an increase in total cholesterol levels. Cholesterol is an important fat substance for the body, but high cholesterol levels can increase the risk of cardiovascular diseases such as coronary heart disease and stroke. This type of research is analytical with a cross-sectional approach. This research method includes quantitative research. The purpose of this study is to determine the relationship between the duration of use of depo medroxy progesterone acetate (DMPA) injectable contraception and cholesterol levels in family planning acceptors. The population in this study were all DMPA injectable contraceptive acceptors who visited PMB Ferawati Palembang. The sample of this study was some of the DMPA injectable contraceptive acceptors who visited PMB Ferawati during the study. From the results of the Chi-Square test, the p value was obtained = 0.002 < α (0.05), this indicates that there is a significant relationship between the duration of using DMPA injectable contraception and cholesterol levels at PMB Ferawati Palembang in 2025